High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA.
about
Non-invasive in vivo imaging of tumor-associated CD133/promininGCPII imaging and cancer.(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors.Molecular imaging of prostate cancer: PET radiotracers.Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncologyNew pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection.A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancerThe evolution of imaging in cancer: current state and future challenges.Prospects in radionuclide imaging of prostate cancer.Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancerProstate-specific membrane antigen-based imaging.PET imaging in prostate cancer: focus on prostate-specific membrane antigenStrategies for imaging androgen receptor signaling pathway in prostate cancer: implications for hormonal manipulation and radiation treatment.The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research.⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer.Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model.Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody.Metal-Based PSMA Radioligands.2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.Radiochemistry and Preclinical PET Imaging of 68Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen.Pre-clinical Imaging of Invasive Candidiasis Using ImmunoPET/MR
P2860
Q27438105-022B44A9-1EBA-482D-A549-E475056D597FQ33827632-F08094A5-6A2C-4FB1-A704-16B457F3EAC6Q35877470-A15ECE4A-8C9C-489C-8B8B-43A1D4F0477DQ36129937-3A0F0B61-6ED4-4E2E-BCCA-2F0C69D7C045Q36339722-17D69374-DB24-4DE9-BDF8-9351CE15C885Q36998151-E3777839-ED0E-414C-81A6-80B153F1D9B6Q37644883-790D5AEA-C3A3-413C-B93C-4466CCDA5F0AQ37848518-58CC9F74-33AC-433A-8AD7-1BA823CA85D8Q37962869-2C77C885-4120-4571-9CE1-34754CE375F3Q37972920-56899423-8B4D-4E06-B076-1B5C5036D2B0Q38015617-A0DF7B60-A3F6-4CCC-85BC-156DB19B3D93Q38099369-6D01D8C8-27FC-43C4-9454-B8749D03D186Q38167022-94E57FDF-8B6D-431E-8C00-D1BB9DB6E1FDQ38169828-FFBBCFB8-ED7F-49B8-940E-1B35960006FAQ38705627-F0F591B0-6D3C-49CA-872F-042ACD619138Q38962393-A9C867D3-5C67-44BC-B689-1680D3E261BFQ39017235-FA33C9A1-CAC4-46F6-B845-8B38459A8506Q39198527-B0D1533B-ADF1-49AB-BC4B-A8B31A96D24BQ39449818-FA196CFD-3C08-495E-BB8C-373F0BA280A5Q45753373-DF2C59FD-CA70-4FBF-9FE1-15430730B98EQ58712631-DD08355A-9BFB-4071-9E4C-75C09C37686C
P2860
High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
High-resolution animal PET ima ...... nst native cell-adherent PSMA.
@en
High-resolution animal PET ima ...... nst native cell-adherent PSMA.
@nl
type
label
High-resolution animal PET ima ...... nst native cell-adherent PSMA.
@en
High-resolution animal PET ima ...... nst native cell-adherent PSMA.
@nl
prefLabel
High-resolution animal PET ima ...... nst native cell-adherent PSMA.
@en
High-resolution animal PET ima ...... nst native cell-adherent PSMA.
@nl
P2093
P356
P1433
P1476
High-resolution animal PET ima ...... inst native cell-adherent PSMA
@en
P2093
Bernd J Pichler
Gerald Reischl
Patrick Bühler
Stefan Wiehr
Ursula Elsässer-Beile
Walter Ehrlichmann
P304
P356
10.1002/PROS.21176
P577
2010-09-01T00:00:00Z